Enumeral Biomedical Holdings, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY16 | FY15 | FY14 | FY13 | FY12 | |
|---|---|---|---|---|---|
| Revenue | — | $1.5M | $164,026 | $449,036 | — |
| Operating income | −$7.0M | −$10.7M | −$6.4M | −$3.8M | −$283 |
| Net income | −$11.9M | $3.3M | −$8.2M | −$3.9M | −$283 |
| Total assets | $4.9M | $6.3M | $15.5M | $1.3M | $5,084 |
| Total liabilities | $1.0M | $3.9M | $17.2M | $1.7M | $367 |
| Equity | $3.9M | $2.5M | −$1.7M | −$405,221 | $449,924 |
| EPS (diluted) | $-0.21 | $0.06 | — | $0.00 | $0.00 |
| Shares out. | 52.1M | 51.6M | 51.6M | 6.2M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2016- Operating margin
- —
- Net margin
- —
- Return on equity
- −303.4%
- Return on assets
- −239.7%
- Return on capital (ROCE)
- −174.9%
- Liabilities / assets
- 21.0%
- Debt / equity
- 0.27×
- Book value / share
- $0.08
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- −460.4%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2016- Altman Z″ (distress)
- -19.60distress
- Accruals / assets
- −125.0%clean
- Piotroski F-Score
- 3/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2017
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Bankruptcy or receivership · Debt acceleration / triggering eventJan 29, 2018
- Delisting / listing-standard noticeDec 19, 2017
- Director / officer changeOct 31, 2017
- Entered a material agreementOct 27, 2017
- Delisting / listing-standard noticeSep 22, 2017
- Director / officer changeSep 5, 2017
- Terminated a material agreementAug 25, 2017
- Results of operations · Other material eventAug 14, 2017
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.